PSC Flare or Cholangitis Attack Patient Survey
News and Announcements
Choose a category:
Winners of the 10th Anniversary Celebration Drawing
Chemomab Announces CM-101 Phase 2 SPRING Trial Results
Positive Update on Pliant’s INTEGRIS-PSC Phase 2a Trial
New Article on an Adaptive Treatment Strategy for Use of Vancomycin in PSC
Expanded Inclusion Criteria for Mirum’s VISTAS PSC Study for Pruritus Treatment
A New Era for the PSC Partners Registry Community
Preliminary Results from INTEGRIS-PSC Phase 2a Clinical Trial
Health Equity in PSC Survey
The VIADUCT Newsletter Issue 6
PRIMIS (Phase 3 Study of Cilofexor) News from EASL Congress 2023
Oral Vancomycin and Insurance Coverage
The VIADUCT Newsletter Issue 5
PRIMIS (Phase 3 Study of Cilofexor) News
The VIADUCT Newsletter Issue 4
The VIADUCT Newsletter Issue 3
The VIADUCT Newsletter Issue 2
Proof of Concept Phase 2 Trial of IMU-838 with Early Positive Results
Clinical Trials Updated: PLN 74809 and Volixibat
Successful registry appeal garners strong support